You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Managing Veno-Occlusive Disease: Optimizing Pharmacist and Nurse Collaboration to Improve Outcomes

  • Authors: Christopher Fausel, PharmD, MHA, BCOP; Karen Wolownik, MSN, RN, CPNP, CPHON
  • CE Released: 8/23/2022
  • Valid for credit through: 8/23/2023
Start Activity

  • Credits Available

    Nurses - 2.00 ANCC Contact Hour(s) (0.75 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for oncology pharmacists, nurses, and nurse practitioners (NPs).

The goal of this activity is that nurse, NP, and pharmacist learners will be better able to have advanced knowledge of how to optimally manage patients at risk for and with veno-occlusive disease (VOD). These important healthcare professionals will be well equipped to identify risk factors and recommend appropriate patient-specific treatments, strategies to optimally prevent and manage toxicity management, and support the healthcare team to improve patient outcomes.

Upon completion of this activity, participants will be able to:

  • Discuss current and emerging evidence for prevention and treatment of VOD
  • Identify interventions to prevent and manage VOD
  • Develop an interprofessional practice model aimed to improve outcomes in patients at risk for and with VOD


Disclosure of Unlabeled Use and Disclaimer

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Healthcare Education, LLC, Postgraduate Institute for Medicine (PIM), or Jazz Pharmaceuticals. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions, and possible contraindications on dangers in use, (review of any applicable manufacturer's product information) and comparison with recommendations of other authorities.

The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this activity have not been evaluated by the FDA.

Faculty Affiliation and Disclosures

  • Christopher Fausel, PharmD, MHA, BCOP

    Clinical Manager, Oncology Pharmacy
    Indiana University Health
    Indianapolis, Indiana


    Dr. Fausel has no relevant affiliations or financial relationships with a commercial interest.

  • Karen Wolownik, MSN, RN, CPNP, CPHON

    Pediatric Nurse Practitioner & Clinical Educator
    Pediatric Oncology & Stem Cell Transplant
    New York Medical Center
    Maria Fareri Children’s Hospital 
    Valhalla, New York


    Ms Wolownik has received consulting fees from: Amgen; Jazz Pharmaceuticals; Omeros; Sanofi.

Additional Planners/Reviewers Information and Disclosure Statements

The clinical reviewer, Lisa Holle, PharmD, has no relevant affiliations or financial relationships with a commercial interest.

The writer, Thomas Cook, RPh, PhD, has no actual or potential conflicts of interest in relation to this program. 

Susanne Batesko, RN, BSN, Robin Soboti, RPh, and Susan R. Grady, MSN, RN, as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education (CE) activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 24 months in relation to this activity. PHE is committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.

The PIM planners and others have no relevant financial relationships.

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Accreditation Statements

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Postgraduate Healthcare Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Nurses

  • Awarded 2.00 contact hour(s) of continuing nursing education for RNs and APNs; 0.75 contact hours are in the area of pharmacology.

    The maximum number of hours awarded for this Continuing Nursing Education activity is 2.0 contact hours.
    Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your

    Published: July 28, 2022
    Expires: July 28, 2023
    Type of Activity: Application
    Media: Internet
    Fee Information: There is no fee for this educational activity.
    Estimated time to complete activity: 120 minutes

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. In addition, you must complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Managing Veno-Occlusive Disease: Optimizing Pharmacist and Nurse Collaboration to Improve Outcomes

Authors: Christopher Fausel, PharmD, MHA, BCOP; Karen Wolownik, MSN, RN, CPNP, CPHONFaculty and Disclosures

CE Released: 8/23/2022

Valid for credit through: 8/23/2023


Before you begin, please answer the questions in this brief questionnaire.

  • Print